Your browser doesn't support javascript.
loading
Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study.
Seitz-Holland, Johanna; Wojcik, Joanne D; Cetin-Karayumak, Suheyla; Lyall, Amanda E; Pasternak, Ofer; Rathi, Yogesh; Vangel, Mark; Pearlson, Godfrey; Tamminga, Carol; Sweeney, John A; Clementz, Brett A; Schretlen, David A; Viher, Petra Verena; Stegmayer, Katharina; Walther, Sebastian; Lee, Jungsun; Crow, Tim; James, Anthony; Voineskos, Aristotle; Buchanan, Robert W; Szeszko, Philip R; Malhotra, Anil K; Kelly, Sinead; Shenton, Martha E; Keshavan, Matcheri S; Mesholam-Gately, Raquelle I; Kubicki, Marek.
Affiliation
  • Seitz-Holland J; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. jseitz@bwh.harvard.edu.
  • Wojcik JD; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. jseitz@bwh.harvard.edu.
  • Cetin-Karayumak S; Department of Psychiatry, Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center, Harvard Medical School, Boston, MA, USA.
  • Lyall AE; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Pasternak O; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Rathi Y; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Vangel M; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Pearlson G; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Tamminga C; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Sweeney JA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Clementz BA; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Schretlen DA; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Viher PV; Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA.
  • Stegmayer K; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, USA.
  • Walther S; Department of Psychology and Neuroscience, Bio-Imaging Research Center, University of Georgia, Athens, GA, USA.
  • Lee J; Department of Psychiatry and Behavioral Sciences, Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Crow T; University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
  • James A; University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
  • Voineskos A; University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
  • Buchanan RW; Department of Psychiatry, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
  • Szeszko PR; Department of Psychiatry, SANE POWIC, Warneford Hospital, University of Oxford, Oxford, UK.
  • Malhotra AK; Department of Psychiatry, SANE POWIC, Warneford Hospital, University of Oxford, Oxford, UK.
  • Kelly S; Center for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Shenton ME; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Keshavan MS; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Mesholam-Gately RI; Mental Illness Research, Education and Clinical Center, James J. Peters VA Medical Center, Bronx, New York, NY, USA.
  • Kubicki M; The Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Mol Psychiatry ; 27(9): 3719-3730, 2022 09.
Article de En | MEDLINE | ID: mdl-35982257
ABSTRACT
Cognitive deficits are among the best predictors of real-world functioning in schizophrenia. However, our understanding of how cognitive deficits relate to neuropathology and clinical presentation over the disease lifespan is limited. Here, we combine multi-site, harmonized cognitive, imaging, demographic, and clinical data from over 900 individuals to characterize a) cognitive deficits across the schizophrenia lifespan and b) the association between cognitive deficits, clinical presentation, and white matter (WM) microstructure. Multimodal harmonization was accomplished using T-scores for cognitive data, previously reported standardization methods for demographic and clinical data, and an established harmonization method for imaging data. We applied t-tests and correlation analysis to describe cognitive deficits in individuals with schizophrenia. We then calculated whole-brain WM fractional anisotropy (FA) and utilized regression-mediation analyses to model the association between diagnosis, FA, and cognitive deficits. We observed pronounced cognitive deficits in individuals with schizophrenia (p < 0.006), associated with more positive symptoms and medication dosage. Regression-mediation analyses showed that WM microstructure mediated the association between schizophrenia and language/processing speed/working memory/non-verbal memory. In addition, processing speed mediated the influence of diagnosis and WM microstructure on the other cognitive domains. Our study highlights the critical role of cognitive deficits in schizophrenia. We further show that WM is crucial when trying to understand the role of cognitive deficits, given that it explains the association between schizophrenia and cognitive deficits (directly and via processing speed).
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Schizophrénie / Troubles de la cognition / Substance blanche Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Mol Psychiatry Sujet du journal: BIOLOGIA MOLECULAR / PSIQUIATRIA Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Schizophrénie / Troubles de la cognition / Substance blanche Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Mol Psychiatry Sujet du journal: BIOLOGIA MOLECULAR / PSIQUIATRIA Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
...